Global HIV Vaccine Enterprise
New York, New York, United StatesPurpose
to convene researchers, advocates, clinicians, policy makers, private sector partners and public health experts in South Africa to share and discuss the latest research in ARV-based prevention, vaccines and related areas of HIV prevention
Grantee
Division
Global Health
Date
JUNE 2013
Region served
GLOBAL
Committed amount
$500,000
Grant topic
HIV
Duration (months)
19
Grantee location
New York, New York, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.